Strategic Partners, Inc., the leader in the manufacturing and marketing of medical apparel, lab wear, footwear and accessories, today announced the launch of its next generation of medical apparel: scrubs, lab wear and accessories protected with CERTAINTY™ antimicrobial technology.
On a daily basis, many healthcare professionals are exposed to unwanted bacteria on their clothing. CERTAINTY antimicrobial technology can provide more fabric protection than traditional scrubs, giving healthcare professionals the freedom to perform their duties in comfortable, fashion-inspired clothing.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7458151-strategic-partners-certainty/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
Dornier MedTech® America, a global medical device company and the pioneer of Extracorporeal Shock Wave Lithotripsy (ESWL®), has received FDA clearance to market the Delta® III. This is the latest generation of the world’s best-selling and most clinically cited lithotripter, the Delta II.
To view the multimedia release go to:
https://www.multivu.com/players/English/8134451-dornier-medtech-delta-iii-kidney-stone-lithotripter/
Results from a new national survey released today indicate that our lifestyle exacerbates the challenge of trying to lose weight, making it more difficult than ever for adults to do so. Findings further suggest that adults who are trying to lose weight need a new approach that’s compatible with how we live today.
Specifically, most healthcare professionals and a majority of U.S. adults say losing weight is harder today than it was for previous generations because of the busy, modern lifestyle of Americans (77% of primary care physicians or PCPs, 81% of pharmacists, 62% U.S. adults). In fact, approximately seven in 10 healthcare professionals say it’s harder for Americans today to lose weight compared to just 10 years ago (69% of PCPs, 73% of pharmacists), and the vast majority believe Americans need to take a new approach to weight loss that fits with today’s modern lifestyle (89% of PCPs, 95% of pharmacists).
To view the multimedia release go to:
https://www.multivu.com/players/English/8215151-the-truth-about-weight-loss-national-survey/
Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at the American Association for Clinical Chemistry (AACC) 2016 Clinical Lab Expo today by featuring several next-generation diagnostic testing platforms and a new virtual reality experience that gives attendees an “under the hood” look at a lab of the future and an innovative concept Roche calls the “Roche connected lab.”
The virtual reality theater will enable attendees to view samples moving through a virtual lab equipped with various configurations of Roche automation, chemistry/immunoassay platforms and molecular diagnostics systems, as well as connections to third-party platforms. The actual Roche systems that are part of the connected lab concept will also be on display in the booth.
To view the multimedia release go to:
http://www.multivu.com/players/English/7889151-roche-aacc-2016/
Children who have disabilities will be able to express their unique experiences like never before thanks to a first-of-its-kind app developed by Gillette Children’s Specialty Healthcare in St. Paul, Minnesota.
The app, an ability-themed emoji keyboard called Emojability, will allow families, patients, caregivers and advocates in the special needs community to communicate, support one another and feel empowered to celebrate the goals and successes they’ve achieved. From adaptive equipment and therapy emojis to words of encouragement, Emojability brings to life symbols and phrases that don’t exist on other emoji keyboards. The free app is now available for download on smartphones.
To view the multimedia release go to:
http://www.multivu.com/players/English/7823251-gillette-childrens-emojability/
A recent survey conducted by DSM Nutritional Products found that 83 percent of adults in the U.S. believe worsening eye health is inevitable with age. What many people don’t realize is that there’s a connection between healthy eyes and proper nutrition, and it goes beyond eating carrots.
According to Dr. Kimberly Reed, optometrist and Ocular Nutrition Society board member, “Incorporating certain nutrients into the diet can support a lifetime of healthy vision and help protect against serious conditions, including cataracts and age-related macular degeneration (AMD). The latter affects more than 2 million Americans and can lead to severe visual impairment.”
To view Multmedia News Release, go to: http://www.multivu.com/players/English/7129751-dsm-nutritional-products-eye-health-survey/
Cigna (NYSE: CI) today unveiled its new TV Doctors of America campaign to encourage people to improve their health by going for their annual check-up, knowing their biometric numbers for blood pressure, cholesterol, blood sugar and body mass index (BMI), and taking control of their health. Supporting Cigna’s effort are actors Patrick Dempsey, Donald Faison, Neil Patrick Harris and Kate Walsh. All four actors starred as doctors on TV and are striking doctor poses, donning scrubs and using their celebrity influence to shine a spotlight on preventive care and the importance of going to a real doctor for an annual check-up that can help save lives.
To view the multimedia release go to:
https://www.multivu.com/players/English/8163851-cigna-americas-tv-doctors-go-know-take-control/
Cardinal Health, which provides medical products and services to many of America’s most prestigious medical institutions, today announced the launch of the Hospital Quality at Home™ brand, a new line of hospital-quality products available over the counter to help loved ones and caregivers transition care from the hospital to home. The product line provides a full assortment of hospital-quality products for consumers categorized as Advanced Wound Care, First Aid, Personal Care, and Home Healthcare which help provide comfort and independence, while helping to promote healing.
When leaving the hospital after childbirth, injury or surgery, the care you provide for yourself or a loved one is important. Each year, hospitals discharge 35.1 million patients1 with 65 percent of those discharged to the home setting for care.2 Effective post-hospital care is critical to avoid re-admission as one in five patients are readmitted within 30 days of discharge.2 With rising health care costs3 the Hospital Quality at Home™ line of products can provide patients, loved ones, and caregivers effective and cost-efficient ways to manage care at home.
To view the multimedia release go to:
http://www.multivu.com/players/English/7622451-cardinal-health-hospital-quality-at-home/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
Nuelle™, a sexual wellness and intimate care company focused on delivering groundbreaking solutions made specifically for women, announces today its Indiegogo campaign to raise awareness and funding for the company’s first product launch Fiera® Arouser for Her™.
In the US, roughly 46% of all American women, aged 18 – 70 have a sexual concern. Among committed couples, intimacy is important for both the health of the relationship and personal wellbeing. Sex, however, is often a tough subject to broach with partners, health care professionals and friends alike. Through its partnership with Indiegogo, Nuelle aims to normalize the conversation about women’s sexual wellbeing and the impact on quality of life, while educating couples about Fiera® Arouser for Her™ and its proven technology to scientifically enhance arousal and desire, naturally.
Co-created with women and healthcare professionals to bring back excitement to connect sexually with her partner, Nuelle’s Fiera® Arouser for Her™ is the first wearable intimacy enhancer used in advance of a sexual experience that is proven to ignite arousal and increase desire among women. In a study (after four weeks of using Fiera), 87% of women said they felt “in the mood” for sex and 83% enjoyed engaging in sex.*
To view the multimedia release go to:
http://www.multivu.com/players/English/7750851-nuelle-indiegogo-fiera-arouser-for-her/
Professor Lionel Tarassenko, CBE, Head of Engineering at the University of Oxford and Fellow of the Royal Academy of Engineering and the Academy of Medical Sciences, has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
As the worlds of science and technology come together, the 2015 Astellas Innovation Debate, organised and funded by Astellas, will discuss recent breakthroughs in genetic medicine and smart technology, and what they mean for our health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7432051-lionel-tarassenko-astellas-debate/
